Zenas BioPharma, Inc.
ZBIO
$16.91
-$0.02-0.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -177.01M | -162.76M | -156.99M | -128.97M | -54.76M |
| Total Depreciation and Amortization | 104.00K | 127.00K | 137.00K | 134.00K | 124.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.79M | 15.30M | 11.75M | 8.19M | 6.39M |
| Change in Net Operating Assets | 9.71M | 9.71M | 25.43M | 24.13M | 14.62M |
| Cash from Operations | -148.41M | -137.62M | -119.67M | -96.52M | -33.62M |
| Capital Expenditure | -92.00K | -127.00K | -131.00K | -74.00K | -74.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -228.97M | -116.68M | -30.42M | -26.76M | -- |
| Cash from Investing | -229.06M | -116.80M | -30.55M | -26.83M | -74.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 20.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 242.57M | 240.97M | 240.91M | 234.64M | 216.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 178.38M | 178.38M | 178.38M | 178.38M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.91M | -5.68M | -6.33M | -1.86M | -1.42M |
| Cash from Financing | 237.65M | 413.67M | 412.96M | 411.16M | 197.18M |
| Foreign Exchange rate Adjustments | -199.00K | 69.00K | 157.00K | -71.00K | -15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.01M | 159.31M | 262.89M | 287.73M | 163.47M |